Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.214
S.214: Preserve Access to Affordable Generics Act
About This Bill
- This bill was introduced in the 113th Congress
- This bill is primarily about commerce
- Introduced Feb. 4, 2013
- Latest Major Action July 23, 2013
- See the six similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
7 (5 Democrats, 1 Independent Democrat, 1 Republican)
Bill Summary
Preserve Access to Affordable Generics Act - Amends the Federal Trade Commission Act to authorize the Federal Trade Commission (FTC) to initiate a proceeding against parties to any agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a drug. Establishes a presumption that any such agreement has anticompetitive effects and is unlawful if the filer of an abbreviated new drug...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
July 23, 2013 |
Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held.
|
Feb. 4, 2013 |
Read twice and referred to the Committee on the Judiciary.
|
Feb. 4, 2013 |
Introduced in the Senate by Amy Klobuchar (D-Minn.) |